Small cap stocks have market capitalization in the range from $300 million to $2 Billion. Companies in this index generally are a little riskier than their other counterparts who have a market cap higher to a few billion dollars, as they are more prone to market updates or economic uncertainties. With this background, below is a look at 4 small-cap stocks.
Clover Corporation Limited (ASX:CLV) is under healthcare segment that caters to the healthcare and nutrition markets. Engaged in the production of encapsulated powders, the company also does the research and product development of functional food and infant nutrition ingredients. The market capitalization of the company is $254.38 million and the stock is trading at a current market price of $1.535 as at August 07, 2018 before market close. The group aims to report better revenues based on rising demand from China.
[optin-monster-shortcode id="wxhmli4jjedneglg1trq"]Bubs Australia Limited (ASX:BUB) is under consumer staples and is a manufacturer of infant milk with a market capitalization of $291.39 million, and the stock is trading at $0.655 as at August 07, 2018, before market close. The company was seeking to raise $40 million, with the offer price of 75 cents a share and the brokers asked for bids. This comes only after Bubs Australia announced a deal, which was well received by the investors, with local manufacturer Australia Deloraine Dairy and online giant Alibaba.
Kogan.com Limited (ASX:KGN), the well-known online retailer has been under some pressure lately while its strategic investments in marketing activities have continued in 4Q FY18, which are expected to provide a strong return on investment but in short term. The stock is trading at a current market price of $5.14 and has seen a performance change of 136% over the past 12 months followed by a slip of 41% in last three months. After the profit forecasts that were missed and a slowdown in sales growth was indicated, shares in kogan.com fell to seven-month low. As new products and services attracted more customers to its sight, the group earlier expected EBITDA to rise more than 90 percent in 2018 helping to boost revenues by more than 40 percent. The group will release the result on August 17, 2018.
Jatenergy Limited (ASX:JAT) is another consumer discretionary stock, to the consumer market in China, and it is focused on selling Australian goods. JATâs 51% owned subsidiary Golden Koala Group Pty Ltd has entered into a supply agreement with AustAgri Pty Limited (AA). For sale in mainland China, Hong Kong, Macau and Taiwan, Golden Koala will supply Golden Koala Premium Range Infant Formulas to AA, as well as via e-commerce platforms. Lately, the group made changes to its board with appointment of Managing director and non-Executive Chairman. The stock is trading at a current market price of $0.077, as at August 07, 2018 before market close. This has been up 1.3% on prior market close price as at August 06, 2018.
The Income available from dividends remains attractive for many investors.
We take a look at the best yields on the market and assess what they say about a companyâs prospect.
One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkineâs team of analysts bought you handpicked report for âTop 25 Dividend Stocks For 2018.â
ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.
Click here to get your free report.
Disclaimer
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.